PTRAQ — Proterra Income Statement
0.000.00%
- $2.64m
- $52.50m
- $309.36m
Annual income statement for Proterra, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 243 | 309 |
Cost of Revenue | |||
Gross Profit | — | 2.05 | -24 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Unusual Expense / Income | |||
Total Operating Expenses | 1.33 | 370 | 520 |
Operating Profit | -1.33 | -128 | -211 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -33.7 | -250 | -238 |
Provision for Income Taxes | |||
Net Income After Taxes | -33.7 | -250 | -238 |
Net Income Before Extraordinary Items | |||
Net Income | -33.7 | -250 | -238 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -33.7 | -250 | -238 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.972 | -2.07 | -1.11 |